Middletown, CT, United States of America

Scott Michael Capitosti




Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Scott Michael Capitosti: Innovator in Pharmaceutical Compounds**

Introduction

Scott Michael Capitosti is an accomplished inventor based in Middletown, Connecticut, with a significant focus on the development of novel pharmaceutical compounds. With three patents to his name, he is dedicated to advancing medical science through his innovative contributions.

Latest Patents

Among his notable inventions are the 2-phenoxy pyrimidinone analogues. These analogues are designed to act as ligands that modulate specific receptor activity, both in vivo and in vitro. Their applications are particularly relevant in treating conditions associated with pathological receptor activation in humans, along with domesticated companion animals and livestock. The patents detail pharmaceutical compositions and methods aimed at treating such disorders, while also exploring the use of these ligands for receptor localization studies.

Career Highlights

Scott currently works with Neurogen Corporation, a company known for its transformative research in the pharmaceutical field. His contributions within the organization underscore his role as a vital player in developing innovative healthcare solutions.

Collaborations

Throughout his career, Scott has collaborated with several accomplished colleagues, including Rajagopal Bakthavatchalam and Bertrand Leo Chenard. These partnerships reflect a commitment to teamwork and shared innovation, enhancing the impact of their collective research efforts.

Conclusion

Scott Michael Capitosti exemplifies the spirit of innovation in the pharmaceutical sector through his groundbreaking patents and collaborations. His work not only aims to provide therapeutic solutions but also enhances our understanding of receptor activity, paving the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…